{"id":"W3003349858","doi":"10.1016/j.eururo.2020.01.019","title":"Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Atezolizumab; Oncology; Urothelial carcinoma; Biomarker; Bladder cancer; Internal medicine; Clinical trial; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008571703,0.0003889076,0.001575105,0.0005582336,0.00003637876,0.00002032538,0.0003865784,0.0003622953,0.0002116748],"category_scores_gemma":[0.0003368096,0.0002628736,0.0003797968,0.0008202978,0.0003463928,0.00002628554,0.0001443969,0.001768792,0.00005348359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004175431,"about_ca_system_score_gemma":0.0001956518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004629011,"about_ca_topic_score_gemma":0.0001175908,"domain_scores_codex":[0.9943486,0.002866763,0.001197692,0.0008306634,0.0003129959,0.0004432183],"domain_scores_gemma":[0.9981814,0.0007230452,0.0002634513,0.0007047994,0.00004020047,0.00008711906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.1566371,0.002026739,0.1360435,0.0002779629,0.006894058,0.06918358,0.004740746,0.00003256252,0.00009153325,0.00001709849,0.5949587,0.02909646],"study_design_scores_gemma":[0.1079303,0.006520469,0.4594917,0.00003988281,0.005760133,0.00008044337,0.0000513573,0.0003303834,0.000003856607,0.00001182348,0.4194158,0.0003637953],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.571489,0.001779688,0.000007756038,0.4062392,0.0007950665,0.002217006,0.0001856205,0.00003884199,0.01724776],"genre_scores_gemma":[0.7018285,0.0002649983,0.00002362277,0.2959174,0.001457212,0.00001952812,0.0002488944,0.00006817851,0.0001716822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3234483,"threshold_uncertainty_score":0.9999824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07430930771093772,"score_gpt":0.3423088906009568,"score_spread":0.267999582890019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}